enzastaurin has been researched along with cyclin d1 in 2 studies
| Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 188 | 52 | 99 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, EE; Kuo, WL; Liu, J; Mauceri, H; Rosner, MR; Vokes, EE; Weichselbaum, R | 1 |
| Fletcher, JA; Giobbie-Hurder, A; Hodi, FS; Wu, X; Zhu, M | 1 |
2 other study(ies) available for enzastaurin and cyclin d1
| Article | Year |
|---|---|
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Topics: Animals; Base Sequence; Carcinoma, Squamous Cell; Cell Cycle; Cell Line; Cell Proliferation; Cyclin D1; DNA Primers; Female; Head and Neck Neoplasms; Humans; Indoles; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Transplantation, Heterologous | 2010 |
The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.
Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Drug Screening Assays, Antitumor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Protein alpha Subunits; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Indoles; Isoenzymes; Melanoma; Mitogen-Activated Protein Kinase Kinases; Molecular Sequence Data; Mutation; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Uveal Neoplasms | 2012 |